The authors report use of intravenous (IV) tissue plasminogen activator (TPA) to treat acute anterior wall myocardial infarction in a forty-two-year-old woman during the active menstrual period. The patient received the TPA with the front-loading system with excellent result. Hemoglobin remained unchanged. This case demon strates that TPA infusion can be used in a menstruating woman without causing a dangerous hemorrhage.
Get full access to this article
View all access options for this article.
References
1.
deGregorio B. , Goldstein J., Haft JI: Administration of intracoronary streptokinase during menstruation. Am Heart J109:908-910, 1985.
2.
Chop WM, Evans PJ, Felty K.: Thrombolytic therapy during active menstruation: A case report. J Family Practice33:79-81, 1991.
3.
Topol EJ: Thrombolytic therapy in acute MI: Safe during menses? J Crit Illness7:14, 1992.
4.
Donovan BC: How to give thrombolytic therapy safely. Chest95:290S-292S, 1989.
